LIBOURNE, France, March 31, 2025 /PRNewswire/ — Ceva Animal Health (Ceva), the world’s fifth-largest animal health company, announces the restructuring of its capital. All investors, whether “Friends of Ceva” or pure investors led by Temasek, have renewed their investment, demonstrating their confidence in the company’s ability to continue its sustained growth.

Ceva’s management, led by Dr. Marc Prikazsky, has reinforced its participation and still retains the majority of voting rights, reaffirming the company’s commitment to remaining independent. It is supported by a core group of long-term investors, known as “Friends of Ceva” ensuring a stable and committed shareholding structure for the group’s development.

With 7,000 employees, Ceva is a global leader in animal health, particularly in vaccination. Operating directly in 47 countries, the company delivers its products, services and equipment’s worldwide to veterinarians, livestock professionals, and pet owners.

To support innovation in animal health, the Bettencourt-Meyers and Mérieux, have increased their stake through the investment holding Téthys Invest and Mérieux Institute that joined forces with investment fund Mérieux Equity Partners. Canadian pension investor PSP Investments, a long-term investor in Ceva, has also significantly increased its ownership in the group. Other companies participating in the “Friends of Ceva” include Sofiprotéol, the investment branch of the French group Avril, the Japanese company Mitsui & Co., as well as some local investment funds and the Klocke family.

The long-standing minority investors have renewed their commitment, demonstrating their confidence in Ceva’s future. Leading this group of partners is the Singapore-based global investment firm Temasek, joined by French investors EMZ and Sagard, Asia-based HOPU Investments, and U.S.-based Continental Grain Company. This sixth funding round also welcomes the addition of the French investment fund ARCHIMED, led by veterinarian Dr. Denis Ribon. Specializing in the healthcare sector, ARCHIMED focuses on supporting companies in expanding internationally and accelerating their research programs.

Since its founding in 1999, Ceva has grown its revenue fourteenfold, reaching €1.77 billion last year. Driven by innovation and deeply committed to preventive medicine, Ceva was the first veterinary company to develop and commercialize a cutting-edge nucleotide vaccine and invest in gene therapy for companion animals. Aware of its responsibility in addressing major global challenges, Ceva is strongly committed to reducing its environmental impact and promoting the preservation of animal biodiversity.

“I am delighted to see that in this new round of financing, the management’s participation, supported by the ‘Friends of Ceva’, is being strengthened alongside our historic financial investors and new entrants. Ceva plays a major role in animal health, particularly in the fight against emerging diseases, sometimes zoonotic, and in the treatment of chronic diseases affecting our loyal four-legged companions. At Ceva, we are convinced that we must continue to create bridges between different health sectors to protect the health of ecosystems and humans as well as global food security,” said Dr. Marc Prikazsky, Chairman and CEO of Ceva Animal Health.

Ceva would like to thank its advisors, Lazard, Rothschild, Weil, and Callisto, and their teams for their support.

About Ceva Animal Health

Ceva Animal Health (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.

Advertisement

With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.

2024 turnover: €1.77 billion

Contact:  Emilie Barrail, Head of external communication, emilie.barrail@ceva.com

Logo – https://mma.prnewswire.com/media/2014922/Ceva_Sant_Animale_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ceva-animal-health-renews-its-shareholding-structure-with-all-its-long-standing-partners-and-opens-its-capital-to-merieux-institute-and-archimed-to-accelerate-its-growth-302414779.html

LONDON, March 31, 2025 /PRNewswire/ — Tetragon has released its Monthly Factsheet for February 2025.

• Net Asset Value: $3,172m
• Fully Diluted NAV per Share: $35.32
• Share Price (TFG NA): $15.45
• Monthly NAV per Share Total Return: -0.8%
• Monthly Return on Equity: -0.7%
• Most Recent Quarterly Dividend: $0.11
• Dividend Yield: 2.8%

Please refer to important disclosures on page three of the Monthly Factsheet.

Please click below to access the Monthly Factsheet.

February 2025 Factsheet

About Tetragon:

Tetragon is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at www.tetragoninv.com.

Tetragon’s non-voting shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors.

Please see: https://www.tetragoninv.com/shareholders/additional-information.

Tetragon Investor Relations:
Yuko Thomas
ir@tetragoninv.com

Press Inquiries:
Prosek Partners
pro-tetragon@prosek.com
U.K. +44 20 3890 9193
U.S. +1 212 279 3115

This release does not contain or constitute an offer to sell or a solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities of Tetragon have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to U.S. persons unless they are registered under applicable law or exempt from registration. Tetragon does not intend to register any portion of its securities in the United States or to conduct a public offer of securities in the United States. In addition, Tetragon has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act. Tetragon is registered in the public register of the Netherlands Authority for the Financial Markets under Section 1:107 of the Financial Markets Supervision Act as a collective investment scheme from a designated country.

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/tetragon-financial-group-limited-february-2025-monthly-factsheet-302414420.html

DURBAN, South Africa, March 31, 2025 /PRNewswire/ — Recently, Yangtze Optics Africa Cable (Pty) Ltd (YOA Cable) solidified its position as the largest optical fibre manufacturer in Africa following a significant expansion investment of optical fibre manufacturing facility, located at the Dube Trade Port in KwaZulu-Natal, a coastal South African province, marking a significant milestone in local optical fibre manufacturing and innovation.

The expansion will also generate additional job opportunities, with about 25% of these positions focused on leadership roles and internships through YOA Cable’s Learnership and Internship Programme. This initiative aligns directly with the Youth Employment Programme, underscoring our commitment to nurturing the next generation of professionals and contributing to the local economy.

Working with other strategic partners, YOA Cable is now able to localise the supply of natural polyethylene supply. This is the first locally produced polyethylene product used in the manufacturing of optical fibre cable in South Africa, in more than 20 years. This is a first-hand example of the positive impact that localisation of the optical fibre supply chain can have.

The facility’s expansion directly responds to the growing demand for high-speed connectivity, fuelled by the rapid digital transformation across industries, including education, healthcare, e-commerce, and government services. It will be crucial in supporting South Africa’s growing digital economy.

With the rapid expansion of 5G and AI-driven technologies, the demand for high-speed connectivity has never been greater. With this increased scale, YOA Cable will now be at the forefront of this digital transformation in South Africa. This development will not only enhance scalability but also strengthen its competitive edge in an increasingly evolving market. The growth initiative will enable YOA Cable to tap into new opportunities beyond South Africa, including neighbouring countries where it has previously seen success, and further enhance efforts to contribute towards the country’s skills development efforts in this highly specialized sector.

The Government of South Africa has welcomed YOA Cable’s investment in the country’s digital infrastructure. According to Yunus Hoosen, Head of Invest SA within the DTIC, “this expansion marks a pivotal moment in the country’s push towards achieving digital inclusivity and strengthening local manufacturing capabilities.”

Hoosen noted that the South African government views this investment as an integral part of the country’s broader digital transformation strategy. The ongoing collaboration between the private sector and government, through initiatives like this, is helping to create a more connected, inclusive, and innovative economy for all South Africans.

Local optical fibre cable manufacturing and expertise will enable direct collaboration with telecom operators and fibre network owners to develop fit-for-purpose products supplied cost effectively. In turn, this will be important in expanding broadband access, bridging the connectivity gaps, and particularly providing connectivity in remote and rural areas to enable greater economic participation.

Since 2014, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC) has significantly expanded international operations as a key component of the company’s globalization roadmap. We now operate over 50 offices worldwide, establishing a robust global marketing and service network that extends across 100 countries and regions. We have established eight production facilities in six countries—Indonesia, South Africa, Brazil, Poland, Germany, and Mexico. The strategic distribution of facilities allows us to customize our operations to meet local demands effectively.

These initiatives not only cater to local markets and boost economic development but also generate significant employment opportunities within these communities. At YOFC, we are dedicated to extending fibre optic connectivity to every corner of the globe. By partnering with industry leaders worldwide, we aim to advance the adoption of fibre technology, bridge the digital divide, and address developmental disparities. Our goal is to ensure that everyone has access to more reliable and high-quality network connections, fostering a digitally enriched quality of life for all.

Advertisement

For more information, please visit YOFC’s website – https://en.yofc.com/ 

View original content:https://www.prnewswire.co.uk/news-releases/africas-largest-optical-fibre-cable-manufacturing-facility-is-set-to-become-a-skills-hub-of-excellence-in-optical-fibre-302415303.html